Breast Pathology
InCyte pathologists interpret over 4,700 breast specimens annually and maintain competency in all aspects of breast pathology, including new approaches to the diagnosis of ductal carcinoma in situ (DCIS) of the breast. Breast biopsy diagnosis is challenging for all pathologists, and has become even more so as imaging-guided biopsies have become smaller, advances in imaging technology detect earlier lesions of breast cancer, and as special testing is requested on smaller samples.
In 2011, InCyte Pathology’s Laboratory Medical Director received the College of American Pathologists (CAP) Breast Predictive Factors Testing Advanced Practical Pathology Program Certificate of Recognition. Designed for pathologists with intermediate or higher skill level in breast predictive factors testing, this selective training program covers the accurate performance and interpretation of breast cancer predictive factors in accordance with the guidelines of the American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP).
Breast cancer develops along a continuum. Pathologists must be able to recognize the changes that stretch from normal cells to what is termed “atypical ductal hyperplasia” to ductal carcinoma in-situ and to invasive carcinoma. InCyte Pathology has long recognized the importance of the breast biopsy interpretation, especially for early lesions.
In 2010, an additional check-and-balance procedure was implemented at InCyte Pathology requiring all negative breast needle core biopsies and lumpectomies be reviewed by a second pathologist. Previously, only positive results were reviewed by another pathologist. In the event a particularly difficult diagnostic case is encountered, or there is disagreement among reviewing pathologists, the biopsy is referred to an outside consultant for expert opinion, especially for difficult cases of DCIS.
Associated Pathologists
Thomas J. Bassler, M.D.
Medical College of Virginia
Residency: LAC-USC Medical Center
Fellowship: Cytopathology, LAC-USC Medical Center
Board Certifications: Anatomic & Clinical Pathology, Cytopathology
Tomas W. King, M.D.
De La Salle University, EAC College of Medicine
Residency: The Mount Sinai Hospital, NewYork NY
Fellowships: Dermatopathology, Thomas Jefferson University; Surgical Pathology The Mount Sinai Hospital, NewYork NY
Board Certification: Anatomic & Clinical Pathology
Sub-specialty Interest: Dermatopathology & Gastrointestinal Pathology
Sanjay Logani, M.D.
Maulana Azad Medical College, Delhi University
Residency: Wayne State University, Detroit, MI
Fellowship: Cytopathology, Hospital of the University of Pennsylvania; Gynecologic pathology, Weill Medical College of Cornell University
Board Certifications: Anatomic & Clinical Pathology, Cytopathology
Felix Martinez, Jr., M.D.
University of Colorado School of Medicine
Residency: University of New Mexico
Fellowships: Surgical Pathology, University of Iowa; Cytopathology & Immunocytochemistry, St. Louis University Medical Center
Board Certifications: Anatomic & Clinical Pathology, Cytopathology
Christopher J. Montague, M.D.
University of Minnesota School of Medicine
Residency: Surgical Pathology, Penrose Hospital
Fellowship: Surgical Pathology, Memorial Sloan Kettering
Board Certification: Anatomic & Clinical Pathology
A. Morgan Wright, M.D.
Pennsylvania State University College of Medicine
Residencies: Penrose Hospital in Colorado Springs, Colorado, and Washington University in St. Louis, Missouri
Board Certification: Anatomic & Clinical Pathology
Sub-specialty Interests: Breast and Genitourinary Pathology
Mancong Zhang, M.D., PhD
Shanghai Medical University
Residencies: Massachusetts General Hospital; Harvard Medical School
Fellowship: Dermatopathology, Harvard Medical School
Board Certifications: Anatomic & Clinical Pathology, Dermatopathology
Sub-specialty Interests: Dermatopathology, Breast Pathology. Bone and Soft Tissue Pathology, Head and Neck Pathology